Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II randomized double-blind placebo-controlled trial of HRN01 tablets for postpartum depression
CTR20263732Phase 2Active
- Sponsor
- Huarui Dingxin
- Start
- Sep 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in postpartum depression (PPD) comparing HRN01 with Placebo (2 arms). Primary endpoint: Change from baseline in depression rating scale score. Started Sep 2026; status: active.
02
Drugs
HRN01
03
Conditions
postpartum depression (PPD)
Beyond the preview
Go deeper on CTR20263732.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20263732.